GoodRx (GDRX) to Release Quarterly Earnings on Thursday

GoodRx (NASDAQ:GDRX) is projected to announce its earnings results before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of $0.10 per share and revenue of $199.73 million for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

GoodRx Price Performance

GDRX stock opened at $5.13 on Thursday. The stock has a market capitalization of $1.96 billion, a PE ratio of -171.00, a price-to-earnings-growth ratio of 2.55 and a beta of 1.28. The company’s 50-day moving average is $4.66 and its 200-day moving average is $5.87. The company has a debt-to-equity ratio of 0.70, a current ratio of 5.48 and a quick ratio of 5.48. GoodRx has a 1 year low of $4.09 and a 1 year high of $9.26.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on GDRX shares. Mizuho began coverage on shares of GoodRx in a research report on Wednesday, December 4th. They set a “neutral” rating and a $5.00 price objective on the stock. Citigroup dropped their price target on shares of GoodRx from $7.00 to $6.25 and set a “buy” rating on the stock in a research report on Friday, January 10th. Barclays dropped their price target on shares of GoodRx from $10.00 to $6.00 and set an “overweight” rating on the stock in a research report on Monday, November 11th. KeyCorp dropped their price target on shares of GoodRx from $7.00 to $6.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 8th. Finally, Morgan Stanley dropped their price target on shares of GoodRx from $7.00 to $6.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Five analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, GoodRx has a consensus rating of “Moderate Buy” and an average target price of $8.38.

About GoodRx

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.